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Immune responses are known to be regulated by complicated interactions of 
T  cells with different functional roles.  In  our previous studies of the cellular 
mechanism of suppression of antibody response in the keyhole limpet hemocyanin 
(KLH)  1 system,  we  have  demonstrated  that  at  least  three  distinct  subsets  of 
suppressor T  cells are involved in the regulatory T  cell interactions (1). 2 These 
T  cell  populations  involve  suppressor  T  cells  that  produce  antigen-specific 
suppressor  T  cell  factor (TsF),  suppressor  T  cells bearing a  receptor  for TsF 
(acceptor-suppressor T  cells), and effector-suppressor T  cells. The KLH-specific 
TsF with antigen-binding moiety and I-J determinants, which is composed of two 
polypeptide chains, is obtained from Lyt-2  + suppresor T  cells. In the initial step 
of the suppressor  pathways, the  KLH-specific suppressor  T  cell  factor (KLH- 
TsF) acts on and activates Lyt-l+,2  + acceptor-suppressor T  cells. In the second 
step, the activated acceptor-suppressor T  cells generate new effector-suppressor 
T  cells that directly suppress  the responses  mounted by B  cells and helper T 
cells. Therefore, the antigen-specific TsF seems not to be an effector-suppressor 
molecule but rather appears to work as a signal to activate the family of suppressor 
T  cells. 
The existence of acceptor-suppressor T  cells was demonstrated by the absorp- 
tion of the TsF activity with Lyt-l+,2  + splenic T  cells in the absence of relevant 
antigen and by the loss of the TsF function after treatment of acceptor T  cells 
with anti-Lyt-1 or anti-Lyt-2 antisera and complementfl Similar populations of 
acceptor-suppressor T  cell types have been described in several other suppressor 
cell systems (2-5)  specific for  4-hydroxy-B-nitrophenyl acetyl (NP),  L-glutamic 
acid~°-L-tyrosine  5°  (GT),  and p-azobenzenearsonate  (ABA),  etc.,  in  which  the 
antigen-binding, idiotype-positive TsF acts on  and stimulates the second order 
of acceptor-suppressor  T  cells  bearing  Lyt-l+,2  ÷ phenotypes and  antiidiotype 
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receptors for the idiotype-positive TsF. The activated second-order acceptor T 
cells then  function  to stimulate  the  Lyt-2  + precursor cells to activate effector- 
suppressor T  cells mediating suppression  in the effector phase of the immune 
response.  It is thus suggested that the acceptor-suppressor T  cells of the inter- 
mediary type play decisive roles in amplifying suppressor signals in regulatory T 
cell interactions. In this sense, the use of monoclonal TsF and suppressor T  cell 
hybridomas  of the  acceptor  cell  type permits  us  to  analyze  this  amplification 
mechanism,  mediated by TsF-acceptor T  cell interaction in the suppression  of 
antibody  response,  at  molecular  levels.  We  describe  here  the  generation  and 
characterization of hybridomas of the acceptor T  cell type that bear a receptor 
for the KLH-TsF composed of two polypeptide chains. The acceptor hybridoma 
cells fail to express any functional activity by themselves, but start to produce 
another "KLH-specific" suppressor  factor possessing  the complementary struc- 
ture that recognizes the KLH-TsF when the cells are stimulated with monoclonal 
or conventional KLH-TsF of the two-chain type in the absence of the relevant 
antigen KLH. The idiotype-antiidiotype network in the KLH-specific suppressor 
system is discussed. 
Materials and  Methods 
Animals.  C57BL/6 CrSlc, and C3H/HeJ CrSIc mice were purchased from Shizuoka 
Experimental Animal Laboratory Co., Ltd., Hamamatsu, Japan. 
Antigens.  KLH was purchased from Calbiochem-Behring Corp., San Diego, CA. Oval- 
bumin (OVA), recrystalized five times, was obtained from Sigma Chemical Co., St. Louis, 
MO.  Dinitrophenylated KLH  (DNP-KLH) and  OVA  (DNP-OVA)  were  prepared  by 
coupling with 2,4-dinitrobenzenesulfonic  acid under alkaline conditions. Bordetella pertussis 
vaccine (BPV) was obtained from the Chiba Serum Institute, Chiba, Japan. 
Antiserum.  Conventional,alloanti-I-J  b,  B10.A(SR) anti-B10.A(3R)  was  raised  in  our 
laboratory by immunization with mitomycin C-treated spleen cells  and  thymocytes, as 
described elsewhere  (6).  Mouse  anti-KLH  and  anti-OVA  antisera  were  produced  by 
immunization of C57BL/6  mice intraperitoneally once or twice with  100 #g  KLH or 
OVA and 1 x  109 BPV. 
Preparation  of Suppressor Factors.  Monoclonal KLH-TsF was obtained in the cell-free 
extracts of suppressor T cell hybridoma cells (34S-18, 34S-704, and 1  L-1) by freezing and 
thawing (extracted TsF) or in the ascitic fluid of hybridoma-bearing mice (secreted TsF) 
as described elsewhere (7).  The conventional KLH-TsF or OVA-TsF was prepared by 
freezing and thawing of the thymocytes from C57BL/6 mice primed twice with 200 ~tg 
of KLH or OVA  at  2-wk  intervals as  described (1).  KLH-TsF has been  found to be 
composed of two polypeptide chains, one having the KLH-binding moiety and constant 
region determinant and the other carrying the I-J determinant detected by B10.A(5R) 
anti-B 10.A(3R)as described elsewhere (6-8). 
Hybridization  and Screening of the Acceptor Hybridoma  Clone.  The acceptor hybridoma 
clone,  34S-281,  was  established  by the  fusion  of BW5147  and  KLH-primed splenic 
suppressor T  cells enriched with KLH-coated petri dishes. This protocol was exactly the 
same as that to obtain KLH-TsF-producing hybridomas as previously reported (7). After 
cloning with limiting dilution, the candidates for acceptor hybridoma cells were screened 
by functional assay to determine whether the cloned hybridoma had the ability to absorb 
the activity of the monoclonal KLH-TsF. The 34S-281  hybridoma line was cloned by 
limiting dilution several times.  The  hybridoma was  cultured and  maintained  in  HAT 
medium (RPMI 1640 containing 1 x  10  -4 M hypoxanthine, 4 X 10  -7 M aminopterin, 1.6 
x  10  -5  M  thymidine) enriched with  10%  fetal  calf serum.  The  hybridoma line  was 
unstable. Therefore, the cells were recloned with limiting dilution and were selected by 
testing  the  absorbing  capacity  of KLH-TsF every  1-2  mo.  By  this  procedure,  the 1914  ACCEPTOR-SUPPRESSOR  HYBRIDOMA 
hybridoma clone, 34S-281, has been maintained for >5 yr. 
Surface  Phenotypes of the  Cloned  Acceptor Hybridoma.  The  cloned  acceptor  hybrid- 
oma  (34S-281)  was  killed  by alloantisera  of anti-H-2  b (C3H  anti-C3H.SW),  anti-H-2  k 
(C57BL/6 anti-C3H), and anti-I-J  b B10.A(5R) anti-B 10.A(3R)). Moreover, the hybridoma 
was killed by the anti-I-J  b absorbed  with  spleen cells of B10.A(5R),  C3H,  or BALB]c, 
while the anti-I-J  h absorbed with C57BL/6 and B10.A(3R) spleen cells failed to kill the 
hybridoma, indicating that the clone 34S-281  is a hybridoma of H-2  k and H-2  b mice and 
expresses I-J  b determinants. Concerning the expression of Thy-1.2 antigens, the cells were 
susceptible to the treatment with monoclonal or conventional anti-Thy-1.2. However, the 
hybridoma cells have not shown Thy-l.2 expression since 2 yr after the hybridization. 
Absorption of Suppressor Factor with Hybridoma Cells.  1 x  107hybridoma cells or BW5147 
thymoma cells were incubated,  with  100  ttl of the ascitic monoclonal KLH-TsF or the 
factor derived from activated hybridoma cells, for 1 h on ice with occasional mixing. The 
process was repeated three times.  The supernates were harvested by centrifugation at 
400 g for 10 min and tested for suppressor activity in the in vitro anti-DNP IgG secondary 
antibody response of C57BL/6 spleen cells primed with DNP-KLH. 
Cytotoxic Test.  The two-step dye exclusion cytotoxic assay was performed as previously 
described (6). 
Activation ofAcceptor Hybridoma with KLH-TsF.  1 X 107 acceptor hybridoma cells (34S- 
281) were incubated with monoclonal KLH-TsF (either cell-free extracts equivalent to 2 
×  106 or  100 ~l of ascitic factor) on ice for 1 h in the absence of relevant antigen. The 
cells were washed three times with  RPMI  1640 and then cultured in RPMI  1640 with 
10% fetal calf serum. As controls, the hybridoma cells were treated with culture medium 
under  the  same conditions  as  the  experimental groups.  The  cell-free extracts  or  the 
culture  supernates  from the  activated  or  nonactivated  acceptor hybridoma cells  were 
prepared  at  different  time  intervals  after  the  stimulation  with  KLH-TsF,  usually  by 
culturing the cells in a fresh medium for 12 h, and were tested for suppressor activity in 
the in vitro secondary IgG antibody response to DNP-KLH. 
Absorption and Elution of Suppressor Factor Produced  by the Activated  Acceptor Hybridoma 
with  lmmunoadsorbent  Columns.  The  methods  of absorption  and  acid  elution  of  the 
suppressor factor, using protein-conjugated Sepharose 4B columns, were described pre- 
viously (7). The extracted suppressor factor was used in this'experiment. 
Assay  for TsF Activity.  The assay systems to detect the suppressor activity of the absorbed 
or unabsorbed monoclonal KLH-TsF or the factor produced by the activated acceptor 
hybridoma  are  the  same as  described  elsewhere  (7).  Briefly,  4  ×  10  ~ spleen  cells  of 
C57BL/6 or C3H mice primed 4 wk previously with DNP-KLH or DNP°OVA and  1 × 
109 BPV were cultured for 5 d in 1-ml wells ofa Mishell-Dutton culture plate with RPMI 
1640 enriched with  10%  fetal calf serum in the presence of 0.1  t~g]ml of DNP-KLH or 
DNP-OVA.  The culture  supernate or cell-free extract of the activated or unactivated 
acceptor hybridoma or the monoclonal KLH-TsF was added to the culture at the start of 
cultivation. Anti-DNP IgG plaque-forming cells (PFC) were enumerated by using DNP- 
coupled sheep erythrocytes as described elsewhere (7). 
Statistical Analysis.  For in vitro assays, results were analyzed with a two-tailed Student's 
t test. The probability value of 10% was considered to be insignificant. 
Results 
Absorption  of Monoclonal  KLH-TsF  with  the  Cloned  Acceptor  Hybridoma.  Our 
previous studies (1) ~ of the cellular mechanisms of the  KLH-specific suppressor 
system have shown that the acceptor-suppressor T  cells have the ability to absorb 
the  KLH-TsF. Therefore,  the cloned acceptor hybridoma cells (34S-281)  were 
tested  for their  ability to absorb the  activity of the  hybridoma  34S-18-derived 
monoclonal  KLH-TsF.  The  monoclonal  KLH-TsF was incubated  with  the  hy- 
bridoma 34S-281  cells, BW5147, or KLH-TsF-producing hybridomas (34S-704, 
34S-18) in the absence of the relevant antigen, KLH, on ice for 1 h. The data in TAKEI,  SUMIDA,  AND  TANIGUCHI  1915 
TABLE  1 
Absorption of Monoclonal KLH-TsF with Various Cloned Hybridoma 
Lines 
Materials  KLH-TsF* ab-  Anti-DNP IgG 
added to the  Function  sorbed with:  PFC/culture  culture* 
None  --  --  2,220 _  610  ~ 
KLH-TsF  Unabsorbed  --  230 +  80 
KLH-TsF  BW5147  None  390 +  210 
KLH-TsF  34S-704  TsF-producer  380 +  270 
KLH-TsF  34S- 18  TsF-producer  610 _+ 210 
KLH-TsF  34S-281  Acceptor  2,920 __. 440 
* The secretory  form of monoclonal  KLH-TsF obtained  in ascitic fluid 
from hybridoma (34S-18)-bearing mice was used. 
* 100 gl of ascitic fluid containing KLH-TsF was incubated with  1 x  l0 T 
cloned  cell  lines on  ice for  1  h.  The  procedures were  repeated  three 
times. The supernates were collected and were tested for their suppres- 
sor activity  in  the  in  vitro  secondary anti-DNP  IgG  PFC  response of 
C57BL/6  spleen cells primed with DNP-KLH. 
Arithmetic means of PFC numbers of three cultures +  SD. 
Table  I  show  that  the  suppressor  activity  of the  monoclonal  KLH-TsF  was 
completely absorbed with the hybridoma 34S-281 but not with two distinct KLH- 
TsF-producing  hybridomas  (34S-704  and  34S-18)  or  with  BW5147  thymoma 
cells that  are parental  cells for the hybridomas.  As the  KLH-TsF seems to be 
directly absorbed by the hybridoma without the antigen-bridging  interaction,  it 
is strongly suggested that the hybridoma cells carry the receptor that recognizes 
the KLH-TsF. 
Kinetics  of the Activation of the Acceptor Hybridoma with KLHoTsF.  Although the 
hybridoma  34S-281  was  supposed  to  bear  a  receptor  for  the  KLH-TsF,  no 
significant  biological  effects on  the  antibody  formation  were obtained  by the 
hybridoma itself. However, based on our previous data obtained in the conven- 
tional KLH-specific suppressor system (1)2 demonstrating that the KLH-TsF acts 
on  and  activates  acceptor-suppressor  T  cells,  it  is  possible  that  the  acceptor 
hybridoma clone established  is activated after  stimulation  with  the  KLH-TsF. 
Therefore,  the  hybridoma  cells  were  incubated  with  the  ascitic,  monoclonal 
KLH-TsF  on  ice  for  1  h,  extensively  washed,  and  then  cultured  in  a  fresh 
medium of RPMI 1640 containing  10% fetal calf serum. The culture supernates 
collected at different time intervals after activation were assayed for suppressor 
activity in the in vitro secondary anti-DNP IgG PFC response of C57BL/6 spleen 
cells primed with  DNP-KLH. As shown in  Fig.  1,  the culture supernate of the 
unactivated  hybridoma cells showed no suppressor activity.  However, the acti- 
vated  hybridoma  cells  started  to  produce  the  suppressor  factor  at  4  h  after 
stimulation  with  the  KLH-TsF.  Maximal suppressive effect was observed after 
12 h of activation with the KLH-TsF and continued for up to >16 d. 
Evidence  that the KLH-TsF Stimulates the Acceptor Hybridoma.  To demonstrate 
that the KLH-TsF does activate the acceptor hybridoma in the resting state, the 
acceptor hybridoma cells were stimulated  with  the  relevant antigen,  KLH, or 
the  monoclonal  KLH-TsF,  unabsorbed  or  absorbed  with  various  immunoad- 1916  ACCEPTOR-SUPPRESSOR  HYBRIDOMA 
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FIGURE  1.  Kinetics  of the activation of the acceptor hybridoma. 1 x  107 acceptor hybridoma 
cells (34S-281) were incubated  with  100 ~1 of ascites containing  KLH-TsF for 1 h on ice, 
thoroughly  washed, and then  cultured  in  fresh  RPM1 1640 enriched  with 10%  fetal calf 
serum.  The  supernates  or the  cell-free extracts  of the activated  or  unactivated  acceptor 
hybridoma cells were prepared by culturing cells in fresh media for 4 h, 8 h, or 16 h, and 
tested for their suppressor activity in the in vitro secondary anti-DNP IgG PFC response of 
C57BL/6  spleen cells primed with DNP-KLH. Quite similar results were obtained by stimu- 
lation with either the supernates  or cell-free extracts of the activated acceptor hybridomas. 
The data represented  here were obtained by using the culture supernates of the activated or 
nonactivated acceptor hybridoma and are expressed as the percent  suppression of the anti- 
DNP IgG PFC responses compared with controls (no factor added). 
sorbent columns. As shown in Table II, no suppressor effect was obtained by the 
incubation  with  KLH.  Moreover,  the stimulatory activity of the  KLH-TsF was 
eliminated  by absorption  with  immunoadsorbent  columns  of KLH  or anti-I-J  b 
but not with the rabbit anti-mouse Fab-conjugated control column. As the KLH- 
TsF was known to have KLH-binding moiety and I-J determinants,  it is demon- 
strated that the KLH-TsF, in fact, works as an element to stimulate the acceptor 
hybridoma. 
Antigen  Specificity and Genetic Restriction of the Suppressor Factor Derived from the 
Activated Acceptor Hybridoma.  Since the activated acceptor hybridoma produced 
the new suppressor factor that was active in the  DNP-KLH system, the antigen 
specificity and genetic restriction specificity of the new factor were investigated. 
The culture  supernates  or  the  cell-free extracts from the  activated hybridoma 
cells were tested for their suppressor activity in the anti-DNP  IgG responses of 
C57BL/6  (H-2  b) mice primed with either DNP-KLH or DNP-OVA, or in those 
of C3H (H-2  k) mice primed with DNP-KLH (Table III). The suppressor factor 
in the culture  supernates or in the  cell-free extracts derived from the activated 
acceptor hybridoma  was only active in  the  responses of C57BL/6  mice against 
DNP-KLH.  However,  no  suppressive  effect  was  obtained  in  the  responses  of 
DNP-OVA-primed  C57BL/6  or  DNP-KLH-primed  C3H  mice.  It  is  demon- 
strated  that  the  newly  induced  factor  of  the  activated  acceptor  hybridoma 
specifically  suppresses  the  antibody  response  of syngeneic  but  not  ailogeneic 
recipients. 
Properties qt  c the New Suppressor Factor Derived from  the Activated  Acceptor Hybri- TAKEI,  SUMIDA,  AND  TANIGUCHI 
TABLE  II 
Evidence that tile Acceptor Hybridoma Is Stimulated  by Two-Chain 
Type of the KLH-TsF 
Acceptor by-  KLH-TsF* absorbed with  Anti-DNP IgG 
bridoma stimu-  columns  PFC/culture  lated with:* 
--  --  2,800 4- 5000 
None  --  2,630 4- 450 
KLH  --  2,760 4- 460 
KLH-TsF  Unabsorbed  1,110 +  540 
KLH-TsF  Anti-mouse Fab  1,190 4- 250 
KLH-TsF  KLH  2,860 4- 360 
KLH-TsF  B10.A(SR) anti-Bl0.A(3R)  2,870 4- 500 
* 1 ×  10  v acceptor hybridoma cells were incubated for  1 h  on ice with 
100 #g KLH or 100 #1 of the extracted monoclonal KLH-TsF (equivalent 
to 2  ×  106 hybridoma cells) that had been unabsorbed or preabsorbed 
with immunoadsorbent columns. They were washed and then cultured 
for  12 h  in fresh media.  The cell-free extracts (equivalent to 3  ×  105 
cells) of the unactivated or activated acceptor hybridomas were added 
to the culture and tested for their activity. 
* 100 #1 of extracted KLH-TsF was applied to and incubated with 1 ml of 
immunoadsorbent  columns  of rabbit anti-mouse  Fab,  KLH,  or 
BI0.A(SR) anti-B10.A(3R) (anti-l-J  b) for  1 h  at 4°C.  After  l-h incuba- 
tion, the effluent from the column was collected and further reacted 
with acceptor hybridoma cells. 
0 Arithmetic means of PFC numbers of three cultures 4- SD. 
TABLE  III 
Spec~city of the New Suppressor Factor Produced by the Activated Acceptor Hybridoma 
1917 
Anti-DNP lgG PFC response to: 
Factor added*  Dose  DNP-KLH  DNP-OVA 
C57BL/6  C3H  C57BL/6 
Exp.  1 
--  --  4,420 4- 170'  2,060 4- 450  1,270 4- 180 
Culture supernates  200 #l  760 4- 140  1,750 4- 210  1,130 _  210 
Culture supernates  50 ~1  6,490 4- 980  2,280 4- 370  1,470 ___ 90 
Exp. 2 
--  --  9,370 +  1,340  1,000 4- 250  1,150-  120 
Extracts  1 ×  105  3,440 _  190  980 4- 250  1,260 +  420 
Extracts  5 ×  l0  b  2,500 4- 1,200  930 4- 250  1,730 4- 140 
* 107 acceptor hybridoma cells were incubated with 100 ~1 of the ascitic monoclonal KLH-TsF for 1 
h on ice, washed, and then cultured in fresh media for  12 h. The culture supernates (50-200 tA/ 
ml) or the cell-free extracts (equivalent to  1-5 x  105 cells) of the activated acceptor hybridoma 
cultured for  12 h  after stimulation were added to the culture of C57BL/6 or C3H spleen cells 
primed with either DNP-KLH or DNP-OVA at the start of cultivation. 
* Arithmetic means of PFC numbers of three cultures 4- SD. 
doma.  The  data  shown  in Table  III demonstrate  that the new  suppressor  factor, 
like the  KLH-TsF,  shows  KLH  specificity and  genetic  restriction  specificity in its 
action.  The  next  experiments  were  designed  to investigate  the  immunochemical 
properties  of  the  newly  induced  suppressor  factor  to  compare  with  the  KLH- 
TsF  that  has  KLH-binding  moiety  and  I-J  b determinants.  The  cell-free  extracts 1918  ACCEPTOR-SUPPRESSOR  HYBR1DOMA 
TABLE IV 
Properties of the New Suppressor Factor Produced by the Activated Acceptor Hybridoma* 
Anti-DNP IgG PFC/culture 
Materials added to  Factor absorbed with:  Extract  the culture  Culture supernates 
Exp. 1  Exp. 2  Exp. 3 
--  --  4,520 +  1,720'  2,900 4- 840  3,960 4- 880 
None  Unabsorbed factor  190 4-  110  650 4- 430  620 4- 360 
B10.A(5R) anti-B10.A(3R)  Effluent  3,410 4- 902  2,800 4- 500  -- 
B10.A(5R) anti-Bl0.A(3R)  Eluate  530 +  530  --  470 _  310 
Rabbit anti-mouse Ig  Effluent  260 _  90  --  -- 
Rabbit anti-mouse Ig  Eluate  3,510 4- 810  --  -- 
KLH  Effluent  500 4- 350  830 4- 770  -- 
KLH  Eluate  5,000 4- 690  --  3,510 4-  100 
*  107 acceptor hybridoma cells were incubated with 100 ul of the ascitic monoclonal KLH-TsF for 1 
h on ice, washed, and then cultured in fresh medium for 12 h. The culture supernates (200 ul/ml) 
or the cell-free extracts (equivalent to 3 x  105 cells) were applied to and incubated with immu- 
noadsorbent  columns for  1 h at 4°C. The effluent or the acid-eluate from the columns was 
concentrated to a final volume of 100 ul by Sephadex G-200 powder and added to the culture of 
C57BL/6 spleen cells primed with DNP-KLH. 
¢ Arithmetic means of PFC numbers of three cultures + SD. 
of the  activated  acceptor  hybridoma  were  applied  to  the  immunoadsorbent 
columns  of antigens  or  antibodies.  The  absorbed  materials  were  eluted  with 
0.175  M  glycine HCI  buffer, pH  3.2,  under the  same conditions as described 
elsewhere (7), and  KLH-TsF was successfully eluted from the KLH or anti-I-J  b 
column. The effluent or the eluate from the column was assayed for its suppressor 
activity in the in vitro anti-DNP IgG antibody response. The suppressor activity 
of the factor from the activated acceptor hybridoma was absorbed to and eluted 
from  the  anti-I-J b column  but  not  from  the  antigen,  KLH,  or anti-mouse  Ig 
(Table IV).  Therefore, the new suppressor factor,  like the KLH-TsF used for 
activation of the acceptor hybridoma, possesses the I-J determinants detected by 
the B10.A(5R) anti-B10.A(3R) antiserum, but this factor, unlike the KLH-TsF, 
has no ability to bind to the relevant antigen, KLH. 
Acceptor Hybridoma  Carries Antiidiotype-like  Structure for KLH-TsF.  The hybri- 
doma appears  to carry a  receptor for the  KLH-TsF.  Furthermore,  the  factor 
produced by the activated acceptor hybridoma shows the inability to bind to the 
KLH column, despite expressing its KLH-specific suppressor activity. Therefore, 
it  is  strongly  suggested  that  the  antiidiotype-like  structure  for  the  KLH-TsF 
makes up the acceptor site for KLH-TsF. 
To demonstrate antiidiotype-like structure on the acceptor hybridoma, three 
sets of experiments were carried out.  First,  the acceptor hybridoma cells were 
activated with monoclonal KLH-TsF or C57BL/6-derived KLH- or OVA-primed 
thymocyte extract to investigate whether the KLH specificity of TsF is required 
for activation. The KLH- or OVA-primed thymocyte extract used was shown to 
have antigen-specific  suppressor  activity in  the  in  vitro antibody  responses  to 
DNP-KLH or DNP-OVA (data not shown). As shown in Table V, the KLH-TsF 
from either the  three different hybridoma or from C57BL/6  thymocytes suc- 
cessfully stimulates the cloned acceptor hybridoma cells, whereas they were not TAKEI, SUMIDA,  AND  TANIGUCHI  1919 
TABLE  V 
Stimulation of Acceptor Hybridoma with Various Antigen-specific Suppressor 
Factors* 
Acceptor hybri-  Anti-DNP IgG 
doma stimulated  TsF derived from: 
with:  PFC/culture 
--  --  2,120 ± 490* 
None  --  2,000 ± 580 
KLH-TsF  Hybridoma (34S- 18)  720 ± 6000 
KLH-TsF  Hybridoma (34S-704)  920 + 420  ! 
KLH-TsF  Hybridoma (1L-l)  920 ± 430  ! 
KLH-TsF  C57BL/6 thymocytes  760 ± 700 
OVA-TsF  C57BL/6 thymocytes  2,550 ± 4901 
*  10  7 acceptor  hybridoma cells were incubated with cell-free extracts obtained 
from three different KLH-specific suppressor hybridomas (equivalent to 2 × 
106) or from C57BL/6 thymocytes (equivalent to 5 ×  107) primed twice with 
200 #g of KLH or OVA. The cells incubated were washed and cultured in 
fresh media for 12 h. The cell-free extracts  of the activated acceptor  hybri- 
doma (equivalent to 3 ×  105 cells) were added to the culture and tested  for 
suppressor activity in the in vitro secondary antibody response to DNP-KLH. 
Arithmetic means of PFC numbers of three cultures _ SD. 
! p < 0.05. 
! Not significant. 
TABLE  VI 
Absorption of New Suppressor Factor with Various Suppressor 
Hybridoma Cells* 
Factor absorbed  Function  Anti-DNP IgG 
with:  PFC/culture 
--  --  1,610  __. 490  s 
None  --  860 __. 1200 
Clone 34S- 18  KLH-TsF producer  1,600 __. 410  ! 
Clone 34S-281  Acceptor  760 _  2100 
* 200 tzl of culture supernatants of the activated acceptor hybridoma cells 
were incubated with 3 × 107 of two different suppressor hybridoma cells 
for  1  h  on  ice. The  procedures  were  repeated  three  times.  After 
absorption, the supernates absorbed or unabsorbed were tested for their 
suppressor activity in the in vitro secondary anti-DNP IgG PFC response. 
* Arithmetic means of PFC numbers of three cultures + SD. 
0p < 0.05. 
! Not significant. 
activated by the OVA-primed thymocyte extracts. The results demonstrated that 
the KLH  specificity of TsF is required for activation of the particular acceptor 
hybridoma cells, suggesting that the acceptor site on the hybridoma recognizes 
the idiotype-like determinants on the  conventional and monoclonal KLH-TsF. 
Second, the factor of the activated acceptor hybridoma was incubated with the 
acceptor hybridoma or the hybridoma-producing KLH-TsF to try to absorb the 
suppressor activity. As shown in Table VI, the suppressor activity of the newly 
induced factor was specifically absorbed by the KLH-TsF-producing hybridoma, 
strongly suggesting that the newly produced suppressor factor bears the comple- 
mentary receptor  for  the  KLH-binding TsF.  Third,  we  attempted  to  kill the 1920  ACCEPTOR-SUPPRESSOR  HYBRIDOMA 
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FIGURE 2.  Cytotoxic  curves  of anti-KLH or anti-OVA antiserum on the acceptor hybridoma 
cells. 5 x  104 acceptor hybridoma cells or BW5147 cells were reacted with C57BL/6 anti- 
KLH or anti-OVA antiserum for 30 rain on ice, washed, and further incubated with 1:10 
diluted rabbit complement. 
acceptor hybridoma cells by anti-KLH antiserum with a dye-exclusion cytotoxic 
assay. The hybridoma cells were reacted with anti-KLH or anti-OVA antiserum 
for 30 min on ice, washed, and further incubated with rabbit complement. As a 
control, BW5147 thymoma cells were treated under the same conditions as the 
experimental groups. The results are shown in Fig. 2. The acceptor hybridoma 
cells were killed  by anti-KLH  antiserum  raised  in  C57BL/6  mice,  but not by 
C57BL/6 anti-OVA antiserum.  The cytotoxic reactivity of anti-KLH antiserum 
on the acceptor hybridoma was specific, because BW5147 thymoma, a parental 
cell line for the acceptor hybridoma, was not killed by the antiserum. 
Discussion 
The  acceptor-suppressor  T  cell  hybridoma  obtained  after  fusion  of KLH- 
primed  C57BL/6  splenic  T  cells described  in  this  report  displayed properties 
distinct from other established T  cell hybridomas that produce antigen-specific 
TsF,  as follows: (a)  The  hybridoma  34S-281  described is a  target  cell for the 
conventional and the hybridoma-derived monoclonal KLH-TsF. Thus, the activ- 
ity  of the  KLH-TsF  is  completely absorbed  by the  acceptor  hybridoma  cells 
(Table  I).  (b) The  hybridoma  cells are  in  a  resting  state,  so that  they do not 
express any functional activity by themselves (Fig.  1). (c) The hybridoma cells in 
the resting stage can, however, be directly activated by KLH-TsF and then start 
to produce the new factor that exerts the KLH-specific suppressor function (Fig. 
1, Table II, and Table III). 
Suppressor  T  cells of the acceptor type have been  demonstrated  in  various 
suppressor systems (2-5),  including  our conventional  KLH-specific suppressor 
system  (1). 2  We  have  found  that  the  KLH-TsF composed of two polypeptide 
chains of KLH-binding and I-J-positive molecules acts on and activates acceptor- 
suppressor T  cells.  In  this  sense,  the acceptor hybridoma  that  was established 
displays similarities  to the acceptor T  cells of this intermediary  cell type in the 
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Minami and his associates (9)  have also identified an inducible suppressor T 
cell  hybridoma obtained  by  the  fusion  of NP-primed precursors  of effector- 
suppressor T  cells. NP-specific hybridomas carried an idiotype-positive receptor 
for the antigen NP and were specifically activated with monoclonal antiidiotypic 
suppressor  factor  to  release  another  NP-specific  idiotype-positive suppressor 
factor.  Minami et al.  (9)  have also demonstrated that the antigen NP was not 
required for activation of NP-specific inducible hybridoma cells. Therefore, the 
properties of these two NP-specific suppressor hybridomas and their factors are 
similar to those of our two types of KLH-specific suppressor hybridomas. The 
hybridoma system described here seems to represent a reciprocal pattern of the 
NP-specific suppressor hybridoma system. 
In any event, the establishment of the hybridoma of the intermediary cell type 
bearing a receptor for TsF permits the analysis of the activation mechanisms in 
the  regulatory T  cell  interactions  and  also  the  characterization of TsF  and 
acceptor-suppressor T  cell interaction at the molecular level.  In fact, the data 
obtained by the experiments described in this report indicate that the acceptor 
hybridoma bears a receptor (acceptor) that recognizes the KLH-TsF. Since the 
relevant antigen, KLH,  is not required for the KLH-TsF acceptor hybridoma 
cell interaction  (Table  II,  Fig.  1),  it  is  assumed that  the acceptor site on  the 
hybridoma  is  composed  of the  complementary structure  for  the  KLH-TsF. 
Furthermore, the complementary structure on the acceptor hybridoma seems to 
be an antiidiotype-like organization for the KLH-TsF, for the following reasons: 
(a) The acceptor hybridoma directly interacts with KLH-TsF in the absence of 
antigen and is specifically activated by KLH-TsF but not by OVA-TsF. Thus, 
the KLH specificity of TsF is essential for activation (Table V). (b) The activated 
acceptor hybridoma cells  start  to  produce  monoclonai suppressor  factor that 
displays the KLH  specificity (Table  III).  However, the new suppressor  factor 
obtained by the activated hybridoma did not have affinity for the antigen KLH 
(Table IV), whereas the KLH-TsF of the two-chain type used for stimulation of 
the acceptor hybridoma bound to the KLH column (7).  (c) The activity of the 
newly induced suppressor factor was absorbed with the suppressor hybridoma 
that produces the KLH-TsF (Table VI).  It is therefore strongly suggested that 
the acceptor site has a complementary structure (antiidiotype) for the KLH-TsF. 
Moreover, the  idiotypic  determinant on  the  KLH-TsF  was  found  to  have  a 
structure similar to that on some of the anti-KLH antibodies, in that the acceptor 
hybridoma was specifically killed by the conventional anti-KLH antibodies plus 
complement (Fig. 2). 
The above evidence demonstrates that even in a conventional antigen system, 
such as  KLH,  the antigen-binding TsF  possesses a  T  cell idiotope  that  cross- 
reacts with  some of the anti-KLH  antibodies.  Predominant idiotypes on anti- 
KLH antibodies have not so far been demonstrated in  various mouse strains, 
including the C57BL/6 mice used in this study. Unlike NP in Igh  b mice such as 
C57BL/6, ABA in A/J mice, or phosphorylcholine (PC) in BALB/c mice, which 
raise the antibodies with major idiotypes (reviewed in 10), it is believed that the 
antigen KLH  equally stimulates a  variety of anti-KLH clones, resulting in  no 
major idiotypes being found on the anti-KLH antibodies. Therefore, the KLH 
system is apparently distinct from other systems in which the antigens, like NP, 1922  ACCEPTOR-SU  PPRESSOR  HYBRIDOMA 
GT, ABA, or PC stimulate only specific clones in particular animals. 
The KLH idiotype expressed on the KLH-TsF described may be predominant, 
especially at the T  cell level, because conventional KLH-TsF has the ability to 
stimulate the particular acceptor hybridoma clone (Table V) and also because 
we have successfully established two distinct suppressor hybridoma clones with 
complementary receptors by  the  fusion  experiment with  a  random  selection 
process. Moreover, the monoclonal KLH-TsF obtained from three independent 
hybridoma clones 34S-18, 34S-704, and 1  L-l) established by the different fusion 
experiments were found to stimulate the cloned acceptor hybridoma 34S-281 
(Table V).  Since the three independent suppressor hybridoma clones and their 
factors have a similar structure that is complementary to the acceptor site of the 
hybridoma clone  34S-281,  it  is  quite  likely that  these  monoclonal  KLH-TsF 
possess  the predominant idiotype.  If so,  the question  to  be asked  is  why the 
particular repertoire limitation in T  cells is dictated even in  the conventional 
antigen system. One possibility is that the family of suppressor T  cells recognizes 
only the limited epitopes (suppressor epitope) on the conventional antigen, as 
measured by Sercarz and his associates (11).  In that case, the suppressor T  cells 
and their factors should bear a  predominant idiotype, whereas B cells or anti- 
bodies can recognize whole epitopes on the KLH molecule. Thus, the idiotype- 
antiidiotype network in  the conventional antigen  system may operate in  the 
interactions more effectively at  T  cell levels than at the T-B levels described 
(reviewed in  12) in various systems using particular antigens such as NP, ABA, 
etc. In fact, the monoclonai "idiotype-specific" TsF derived from the activated 
acceptor hybridoma suppressed the majority of antibody responses against total 
epitopes  on  KLH  macromolecules.  It  is  thus  suggested  that  the  monoclonal 
idiotype-specific TsF may effectively induce the idiotype-bearing suppressor T 
cells that recognize one of the epitopes of the KLH molecule by which the whole 
anti-KLH  antibody responses are suppressed via antigen-bridging interaction. 
Experiments to prove these possibilities are being now undertaken. 
Summary 
An acceptor hybridoma with a  receptor that recognizes the keyhole limpet 
hemocyanin (KLH)-specific suppressor T  cell factor (KLH-TsF) was established 
after the fusion of C57BL/6  splenic T  cells enriched with  KLH-coated petri 
dishes.  The  cloned  hybridoma  (34S-281)  could  be  specifically  activated  by 
stimulation with the conventional KLH-TsF or monoclonal KLH-TsF from three 
different hybridomas in the absence of the relevant antigen (KLH) and it started 
to produce another factor that suppresses the antibody response against DNP- 
KLH in a  KLH-specific fashion. The KLH specificity of the TsF was required 
for activation. The new factor was found not to bind the KLH but to be absorbed 
with the KLH-TsF-producing hybridoma. It is thus strongly suggested that the 
acceptor site  has a  complementary structure (antiidiotype) for the  KLH-TsF. 
Moreover, the idiotypic determinant on KLH-TsF was found to have a structure 
similar to that on some of the anti-KLH antibodies, since the acceptor hybridoma 
was specifically killed by'the conventional anti-KLH antibodies and complement. 
Drawing on the above results, the idiotype-antiidiotype network in the conven- 
tional antigen system is discussed. TAKEI,  SUMIDA, AND  TANIGUCHI  1923 
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